NCT02811692View on ClinicalTrials.gov

Study for Collection of Aflibercept Data in Routine Practice

CompletedOBSERVATIONAL

Enrollment

425

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 27, 2017

Study Completion Date

November 27, 2017

Conditions

Eye Diseases

Interventions

DRUG

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

Administration by intravitreal injection

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Bayer

INDUSTRY